Market Overview

8 Stocks Moving In Monday's After-Hours Session

Share:

Gainers

  • Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares were up more than 18% following better-than-expected second-quarter results.
  • Bloom Energy Corporation (NYSE: BE) shares were up 10% following second-quarter results that showed a loss of 55 cents per share on sales of $233.8 million.
  • FlexShopper, Inc. (NASDAQ: FPAY) shares traded nearly 8% higher following a second-quarter beat and raised 2019 guidance.
  • Greenlane Holdings, Inc. (NASDAQ: GNLN) shares were up about 6% amid second-quarter sales of $52.99 million, better than the analyst consensus estimate of $50 million.
  • OptiNose, Inc. (NASDAQ: OPTN) shares were up following strong second-quarter earnings and sales figures.

Losers

  • Victory Capital Holdings, Inc. (NASDAQ: VCTR) shares traded nearly 20% lower following second-quarter earnings of 38 cents per share vs. the analyst consensus estimate of 39 cents per share. Sales also missed at $91.36 million.
  • Tencent Music Entertainment Group (NYSE: TME) shares were down following the company's second-quarter results.
  • Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) shares fell about 4% following news of a $200-million common stock offering.

Posted-In: News After-Hours Center Movers Trading Ideas

 

Related Articles (BE + FPAY)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at [email protected]

Service Reliability Issues And Trade Uncertainty Could Help Push U.S. Rail Volumes Lower

IPO Outlook For The Week: Biotech, Banking and Chinese Fintech